Last reviewed · How we verify
Midazolam , Rosuvastatin calcium and digoxin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Midazolam , Rosuvastatin calcium and digoxin (Midazolam , Rosuvastatin calcium and digoxin) — Allist Pharmaceuticals, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Midazolam , Rosuvastatin calcium and digoxin TARGET | Midazolam , Rosuvastatin calcium and digoxin | Allist Pharmaceuticals, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Midazolam , Rosuvastatin calcium and digoxin CI watch — RSS
- Midazolam , Rosuvastatin calcium and digoxin CI watch — Atom
- Midazolam , Rosuvastatin calcium and digoxin CI watch — JSON
- Midazolam , Rosuvastatin calcium and digoxin alone — RSS
Cite this brief
Drug Landscape (2026). Midazolam , Rosuvastatin calcium and digoxin — Competitive Intelligence Brief. https://druglandscape.com/ci/midazolam-rosuvastatin-calcium-and-digoxin. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab